SCHEMBL8964576

SCHEMBL8964576

O=C(c1cncc(Br)c1)c1cccc(N2CCC(N3CCCC3)CC2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 8/20 0.57
L3MBTL1 Q9Y468 7/20 0.57
L3MBTL4 Q8NA19 2/20 0.57
MBTD1 Q05BQ5 2/20 0.47
HSD17B14 Q9BPX1 2/20 0.46
OPRK1 P41145 1/20 0.44
HRH3 Q9Y5N1 1/20 0.42
HSD11B1 P28845 3/20 0.42
HTT P42858 2/20 0.41
ALOX15 P16050 1/20 0.41
PRKCQ Q04759 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8964827 0.99 L3MBTL3 (0.56) L3MBTL3L3MBTL1L3MBTL4MBTD1HSD17B14
SCHEMBL15930667 0.92 L3MBTL3 (0.49) L3MBTL3L3MBTL1L3MBTL4MBTD1HSD17B14
SCHEMBL8964313 0.89 HSD17B14 (0.49) L3MBTL3L3MBTL1L3MBTL4MBTD1HSD17B14
SCHEMBL9011442 0.81 PRKCQ (0.54) OPRK1HRH3PRKCQ
SCHEMBL9011525 0.80 PRKCQ (0.53) MBTD1OPRK1HRH3HSD11B1PRKCQ
SCHEMBL8963966 0.80 HSD17B14 (0.55) HSD17B14HSD11B1HTTALOX15PRKCQ
SCHEMBL8964454 0.79 HSD17B14 (0.42) HSD17B14HSD11B1HTTALOX15PRKCQ
SCHEMBL8964520 0.78 HTT (0.49) L3MBTL3L3MBTL1HSD17B14HRH3HSD11B1
SCHEMBL8964821 0.78 ALOX15 (0.44) HSD17B14HTTALOX15PRKCQ
SCHEMBL8964283 0.78 HSD17B14 (0.45) L3MBTL3L3MBTL1HSD17B14HTTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188071-B2 Amino substituted pyridines as potent kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-05-29 US disclosed